Aardvark Therapeutics (AARD) said late Wednesday it priced an initial public offering of about 5.9 million common shares at $16 each.
The company anticipates raising approximately $94.2 million in gross proceeds.
The underwriters of the offering, expected to close on Friday, have an option to buy 883,200 more shares.
The shares are scheduled to begin trading on the Nasdaq Global Select Market on Thursday under the ticker symbol "AARD."
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
No relevant data is available
If the download button clicks without skipping, click on the top right menu and select "Open in Browser."